Institutional investors purchased a net $8.1 million shares of CVM during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 11.03% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 40.0 Thousand shares of CEL-SCI Corp